UniProt ID | CHM4C_HUMAN | |
---|---|---|
UniProt AC | Q96CF2 | |
Protein Name | Charged multivesicular body protein 4c | |
Gene Name | CHMP4C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 233 | |
Subcellular Localization |
Cytoplasm, cytosol. Late endosome membrane Peripheral membrane protein . Midbody, Midbody ring . Localizes to the midbody during late cytokinesis. During its recruitment, localizes initially to the midbody arms, before being directed to the central |
|
Protein Description | Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: upon phosphorylation by AURKB, together with ZFYVE19/ANCHR, retains abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ANCHR and VPS4 and subsequent abscission. [PubMed: 22422861] | |
Protein Sequence | MSKLGKFFKGGGSSKSRAAPSPQEALVRLRETEEMLGKKQEYLENRIQREIALAKKHGTQNKRAALQALKRKKRFEKQLTQIDGTLSTIEFQREALENSHTNTEVLRNMGFAAKAMKSVHENMDLNKIDDLMQEITEQQDIAQEISEAFSQRVGFGDDFDEDELMAELEELEQEELNKKMTNIRLPNVPSSSLPAQPNRKPGMSSTARRSRAASSQRAEEEDDDIKQLAAWAT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | KFFKGGGSSKSRAAP CCCCCCCCCCCCCCC | 37.56 | 26434776 | |
14 | Phosphorylation | FFKGGGSSKSRAAPS CCCCCCCCCCCCCCC | 37.61 | 24719451 | |
16 | Phosphorylation | KGGGSSKSRAAPSPQ CCCCCCCCCCCCCHH | 29.15 | 23403867 | |
21 | Phosphorylation | SKSRAAPSPQEALVR CCCCCCCCHHHHHHH | 34.19 | 23403867 | |
70 | Ubiquitination | RAALQALKRKKRFEK HHHHHHHHHHHHHHH | 66.25 | 32015554 | |
80 | Phosphorylation | KRFEKQLTQIDGTLS HHHHHHHHHCCCCHH | 22.45 | 27251275 | |
146 | Phosphorylation | QDIAQEISEAFSQRV HHHHHHHHHHHHHHH | 23.32 | 20058876 | |
190 | Phosphorylation | IRLPNVPSSSLPAQP CCCCCCCHHHCCCCC | 28.42 | 26657352 | |
191 | Phosphorylation | RLPNVPSSSLPAQPN CCCCCCHHHCCCCCC | 29.80 | 28857561 | |
192 | Phosphorylation | LPNVPSSSLPAQPNR CCCCCHHHCCCCCCC | 42.59 | 28857561 | |
204 | Phosphorylation | PNRKPGMSSTARRSR CCCCCCCCHHHHHHH | 30.38 | 22210691 | |
210 | Phosphorylation | MSSTARRSRAASSQR CCHHHHHHHHHHHHH | 22.25 | 22422861 | |
214 | Phosphorylation | ARRSRAASSQRAEEE HHHHHHHHHHHHHHC | 26.47 | 27273156 | |
215 | Phosphorylation | RRSRAASSQRAEEED HHHHHHHHHHHHHCC | 20.96 | 27273156 | |
233 | Phosphorylation | KQLAAWAT------- HHHHHHHC------- | 28.57 | 24719451 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
210 | S | Phosphorylation |
| 22422861 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHM4C_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PDC6I_HUMAN | PDCD6IP | physical | 14505570 | |
CHM4A_HUMAN | CHMP4A | physical | 14505570 | |
CHM4B_HUMAN | CHMP4B | physical | 14505570 | |
VPS4A_HUMAN | VPS4A | physical | 14505570 | |
CHM4C_HUMAN | CHMP4C | physical | 14505570 | |
C2D1A_HUMAN | CC2D1A | physical | 16730941 | |
TP4AP_HUMAN | TRPC4AP | physical | 16730941 | |
PDC6I_HUMAN | PDCD6IP | physical | 21988832 | |
CHM1B_HUMAN | CHMP1B | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...